STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) Free cash flow margin
STERIS plc's free cash flow margin over the twelve months to 30 June 2026 was 15.5%, down 1.1 percentage points from fiscal 2026 (16.6%). Over the past ten years it has ranged from 5.77% (fiscal 2016) to 16.6% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −7.24% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2026 | 16.6% | 2.14 |
| FY2025 | 14.4% | 2.35 |
| FY2024 | 12.1% | 3.04 |
| FY2023 | 9.03% | (0.42) |
| FY2022 | 9.45% | (5.06) |
| FY2021 | 14.5% | 1.97 |
| FY2020 | 12.5% | (0.23) |
| FY2019 | 12.8% | 1.54 |
| FY2018 | 11.2% | 1.43 |
| FY2017 | 9.80% | 4.03 |
Against its own ten years
Low 5.77%
High 16.6%
Ten-year median
11.6%
Current reading's percentile
100
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| DXCM DexCom, Inc. compare | 28.3% |
| STE STERIS plc | 15.5% |
| PEN Penumbra, Inc. compare | 14.4% |
| BIO Bio-Rad Laboratories, Inc. compare | 13.6% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 13.6% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 12.2% |
| PHG Koninklijke Philips N.V. compare | 8.99% |
| GEHC GE HealthCare Technologies Inc. compare | 7.42% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −7.24% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement